Stock Events

Stock Events

Alpha Compute 

$0.4066
55
-$0.03-7.4% Friday 12:58

Statistics

Day High
0.4391
Day Low
0.4391
52W High
10.91
52W Low
0.183
Volume
2,000
Avg. Volume
-
Mkt Cap
2.52M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

23JulExpected
Q4 0
Q3 2024
Q4 2025
Q2 2026
-1.26
-0.95
-0.65
-0.34
Expected EPS
-0.34
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-6.77MNet Income

Analyst Ratings

0.25Average Price Target
The highest estimate is 0.25.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ATON. It's not an investment recommendation.
NVIDIA
7
NVDA
Micron Technology
7
MU
Microsoft
6
MSFT
Realty Income
6
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.75B
CRISPR Therapeutics focuses on gene editing, competing in the innovative biotech therapies space similar to Portage.
Editas Medicine
EDIT
Mkt Cap477.63M
Editas Medicine is also involved in gene editing technology, directly competing with Portage's biotech innovations.
Intellia Therapeutics
NTLA
Mkt Cap1.8B
Intellia Therapeutics is a key player in CRISPR/Cas9 technology, a direct competitor in the genetic medicine field.
Biomarin Pharmaceutical
BMRN
Mkt Cap12.91B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals, overlapping with Portage's market.
Alnylam Pharmaceuticals
ALNY
Mkt Cap31.61B
Alnylam Pharmaceuticals works on RNAi therapeutics, competing in the novel biopharmaceuticals space.
Sarepta Therapeutics
SRPT
Mkt Cap1.98B
Sarepta Therapeutics focuses on the discovery and development of RNA-targeted medicine, similar to Portage's approach.
Beam Therapeutics
BEAM
Mkt Cap3.07B
Beam Therapeutics uses base editing technology, a novel approach in the competitive genetic medicine industry.
Voyager Therapeutics
VYGR
Mkt Cap208.88M
Voyager Therapeutics focuses on severe neurological diseases with gene therapy, competing in the advanced therapy sector.

About

Alpha Compute Corp owns and operates AI infrastructure powered by confidential compute and hardware-level encryption. Alpha Compute's GPU assets deliver privacy-preserving computation to partners and applications including Telegram, Animoca Brands, and Midnight Network.
Show more...
CEO
Brittany Kaiser
Employees
2
Country
Canada
ISIN
VGG7185A1369

Listings

XNAS
US
ATON
XNAS
US
ALP
BOATS
BOATS
ATON.BOATS

0 Comments

Share your thoughts

FAQ

What is Alpha Compute stock price today?▼
The current price of ATON is $0.41 USD — it has decreased by -7.4% in the past 24 hours. Watch Alpha Compute stock price performance more closely on the chart.
What is Alpha Compute stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Alpha Compute stocks are traded under the ticker ATON.
Is Alpha Compute stock price growing?▼
ATON stock has fallen by -6.54% compared to the previous week, the month change is a +39.72% rise, over the last year Alpha Compute has showed a -93.9% decrease.
What is Alpha Compute market cap?▼
Today Alpha Compute has the market capitalization of 2.52M
What is Alpha Compute revenue for the last year?▼
Alpha Compute revenue for the last year amounts to 0 USD.
What is Alpha Compute net income for the last year?▼
ATON net income for the last year is -6.77M USD.
How many employees does Alpha Compute have?▼
As of August 29, 2026, the company has 2 employees.
In which sector is Alpha Compute located?▼
Alpha Compute operates in the Technology sector.
When did Alpha Compute complete a stock split?▼
The last stock split for Alpha Compute was on August 15, 2024 with a ratio of 1:20.
Where is Alpha Compute headquartered?▼
Alpha Compute is headquartered in Dover, Canada.